… remedy and a promising way to manage COVID-19. These approaches are based on …
passive immunotherapy and immunomodulation approaches in managing and treating COVID-19 …

… COVID‐19 is a historic pandemic that is testing … , passive immunotherapies to manage
COVID‐19 may prove to be effective agents in the fight against SARS‐CoV‐2 and COVID‐19. …

… to the COVID-19 pandemic, the present article is dedicated to evaluating the benefits and
risks of different CBPs to achieve artificially acquired passive … in the COVID-19 pandemic. …

… like passive immunotherapy, there is no advertised monoclonal antibody for COVID-19. Using
… this review, we conclude that immunotherapy is an effective treatment against COVID-19. …

… Passive immunotherapy via neutralizing antibodies has been considered as a possible
strategy for defeating COVID-19 apart from anti-viral therapeutics and vaccines (Fig. 1). …

… Given the limited drug options, clinicians began to use passively transferred immune serum
… using passively transferred immune serum as a form of immunotherapy for COVID-19 comes …

… Despite major progress in the development of monoclonal antibody-based passive
immunotherapy for coronavirus infection, there is no marketed monoclonal antibody. What limits the …

… immunotherapies as an adjunct therapy in severe COVID-19 cases. Such immunotherapies
based on inflammatory cytokine neutralization, immunomodulation, and passive viral …

… The COVID-19 pandemic is now approaching 2 years old, with more than 440 million …
Finally, antibodies being developed for palliative care of COVID-19 disease, including the …

… Abstract: [eng] Introduction: Passive immunotherapy has been proposed as a potential … the
COVID-19 pandemic, passive immunotherapies, including the use of COVID-19 convalescent …